Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127942351 | 12794235 | 1 | I | 20060107 | 20150706 | 20160929 | 20160929 | PER | US-JNJFOC-20150713222 | JANSSEN | 4.53 | YR | C | M | Y | 126.00000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127942351 | 12794235 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.25 AND 1 MG | U | U | 0 | UNSPECIFIED | |||||||
| 127942351 | 12794235 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | UNSPECIFIED | ||||||
| 127942351 | 12794235 | 3 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 20272 | .5 | MG | UNSPECIFIED | ||||||
| 127942351 | 12794235 | 4 | SS | INVEGA | PALIPERIDONE | 1 | Oral | U | U | 0 | 3 | MG | OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET | ||||||
| 127942351 | 12794235 | 5 | SS | INVEGA | PALIPERIDONE | 1 | Oral | U | U | 0 | 3 | MG | OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET | ||||||
| 127942351 | 12794235 | 6 | SS | INVEGA | PALIPERIDONE | 1 | Oral | U | U | 21999 | 3 | MG | OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET | ||||||
| 127942351 | 12794235 | 7 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127942351 | 12794235 | 8 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127942351 | 12794235 | 1 | Attention deficit/hyperactivity disorder |
| 127942351 | 12794235 | 2 | Attention deficit/hyperactivity disorder |
| 127942351 | 12794235 | 3 | Attention deficit/hyperactivity disorder |
| 127942351 | 12794235 | 4 | Attention deficit/hyperactivity disorder |
| 127942351 | 12794235 | 5 | Attention deficit/hyperactivity disorder |
| 127942351 | 12794235 | 6 | Attention deficit/hyperactivity disorder |
| 127942351 | 12794235 | 7 | Product used for unknown indication |
| 127942351 | 12794235 | 8 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127942351 | 12794235 | Abnormal weight gain | |
| 127942351 | 12794235 | Gynaecomastia | |
| 127942351 | 12794235 | Hyperglycaemia | |
| 127942351 | 12794235 | Off label use | |
| 127942351 | 12794235 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127942351 | 12794235 | 1 | 2008 | 2010 | 0 | |
| 127942351 | 12794235 | 2 | 20060107 | 20080825 | 0 | |
| 127942351 | 12794235 | 3 | 20080723 | 0 | ||
| 127942351 | 12794235 | 4 | 20090417 | 0 | ||
| 127942351 | 12794235 | 5 | 2009 | 2009 | 0 | |
| 127942351 | 12794235 | 6 | 20090729 | 0 |